Montelukast Prescribing at WHITEWATER HEALTH
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
1,406
Total Quantity
51.0K
NHS Cost
£2.7K
vs National Avg
+105.3%
WHITEWATER HEALTH prescribed 1,406 items of Montelukast over the last 12 months at a cost of £2,718 to the NHS. This is 105.3% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
131
Jul 2026
124
Jul 2026
126
Jul 2026
106
Jul 2026
120
Jul 2026
135
Jul 2026
114
Jul 2026
123
Jul 2026
125
Jul 2026
102
Jul 2026
108
Jul 2026
92
Prescribing Details
| Total Items | 1,406 |
|---|---|
| Total Quantity | 50,988 |
| Total NHS Cost | £2,718 |
| Presentations | 5 different forms |
| vs National Average | +105.3% |
Montelukast Prescribing Comparison
| This practice | 1,406 items |
|---|---|
| National average per practice | 685 items |
| Difference | +105.3% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.